The Medicine Maker / Issues / 2020 / Aug / Enter Lipid Nanoparticles
Manufacture Drug Delivery Formulation Outsourcing Technology & Manufacturing Supply Chain Sponsored

Enter Lipid Nanoparticles

Formulation fit for the future of complex medicines.

08/22/2020 0 min read

Sponsored By

Share

Enter lipid nanoparticles – a formulation approach fit for the future of complex molecules. Experts from Exelead including Rahul Keswani, Benjamin King, Larry Beiter, and Kim Rice give their view on the current market for LNP formulations, how to navigate technology transfer, and the challenges posed by the supply chain.

Recommended

Related Content

Meeting the Demands of Injectable Drug Delivery
Drug Delivery
Meeting the Demands of Injectable Drug Delivery

October 22, 2026

1 min read

Stevanato Group’s Adam Stops discusses how delivery systems and manufacturing capabilities can keep pace with increasingly complex drug formulations

Choosing a Sterile Fill-Finish Partner
Outsourcing
Choosing a Sterile Fill-Finish Partner

October 22, 2026

5 min read

Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner

Prula-cel Shows Early Promise in Lupus
Drug Delivery Cell & Gene Industry News
Prula-cel Shows Early Promise in Lupus

October 8, 2026

2 min read

Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy

Video Sitting Down With John Tomtishen
Outsourcing Cell & Gene Sitting Down With
Video: Sitting Down With… John Tomtishen

October 7, 2026

1 min read

Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization